Our Media - COVID-19 clinical trial impact and potential mitigation

Latest content from Pharmetheus.

COVID-19 clinical trial impact and potential mitigation

Fewer subjects, shorter duration, missingness patterns and dosing interruptions.

September 12, 2020

The ongoing pandemic continues to influence the conduct of clinical trials in all therapeutic areas. In this video, our Chief Statistician Richard Anziano describes how the COVID-19 impact on studies can be understood and mitigated, using modeling and simulation approaches.

COVID-19 clinical trial impact and potential mitigation